Helix Medical, a division of the Freudenberg Group, has completed the acquisition of MedVenture Technology for an undisclosed sum.
MedVenture’s commercial products include minimally invasive surgical and catheter-based devices used in various procedures.
The company also develops integrated solution, designed for use in cardiology, cardiovascular surgery, gynecology, endovascular, interventional, neurovascular, oncology and urology markets.
Helix Medical president and CEO Jorg Schneewind said the acquisition will enable the company to provide its customers with a full spectrum of design and manufacturing services.
"While our global reach, with now 10 facilities around the world, will allow MedVenture to expand their services into new regions and tap into Helix’s core strengths in thermoplastic and silicone molding and extrusion plus specialty catheters and hypotubes," Schneewind added.
"Overall, the combined companies deliver a perfect synergy of complimentary capabilities powered by highly innovative people, advanced technology, and leading-edge processes."
MedVenture Technology CEO Kevin Bramer said with the acquisition, the company plans to leverage the additional resources to continue its achievements in the design, development and manufacture of minimally invasive medical devices.
"Superior patient care begins with the newest technology and design strategies delivered with consistency and expertise," Bramer added.
"MedVenture’s accomplished team, combined with Helix Medical’s core manufacturing services, will allow us to continue to provide superior devices for first-rate patient care."